Shares of Shineco Inc. (NASDAQ:SISI) climbed 6.1% in premarket trading Wednesday after the company announced a strategic partnership with Singapore-based BICC Pte Ltd to jointly promote “on-chain cell assets” across multiple institutions and use cases.
The agreement is designed to advance the real-world asset (RWA) ecosystem, moving from technical integration to practical deployment, and to establish a cross-enterprise redeemable system for cell assets on the blockchain. As part of the collaboration, BICC’s induced pluripotent stem cell (iPSC) storage services will be incorporated into Shineco’s blockchain platform, allowing holders of “Cell Reimbursement Vouchers” to redeem them at designated BICC locations.
This partnership builds on Shineco’s prior initiatives, including the launch of a Cell Digital Division, collaboration with Plus Me Limited for on-chain cell asset management, and the acquisition of a 51% stake in Xi’an Dong’ao Health Management Co., Ltd.
Within the alliance, Shineco will concentrate on cell quality and offline network standardization, while BICC will focus on user services and scenario integration. BICC’s extensive distribution network of over 3,000 sales representatives will act as additional nodes for Shineco’s “storage + reinfusion” network, helping to address inefficiencies in traditional cross-regional cell service circulation.
The companies also plan to work with technical partners to customize on-chain modules and compliance tools, ensuring alignment with local regulations and internal risk controls. Plus Me will manage the full lifecycle of Shineco’s compliant mesenchymal stem cells on the Ethereum mainnet.
Jennifer Zhan, CEO of Shineco, emphasized that the company is “transitioning from a single technical service provider to a global cell economy infrastructure provider.”
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.